BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37669997)

  • 1. Independent association between age- and sex-specific metabolic syndrome severity score and cardiovascular disease and mortality.
    Honarvar M; Mehran L; Masoumi S; Agahi S; Khalili S; Azizi F; Amouzegar A
    Sci Rep; 2023 Sep; 13(1):14621. PubMed ID: 37669997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic Risk Score and Vascular Mortality Among Korean Adults.
    Jung KJ; Jee YH; Jee SH
    Asia Pac J Public Health; 2017 Mar; 29(2):122-131. PubMed ID: 28118734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender differences in changes in metabolic syndrome status and its components and risk of cardiovascular disease: a longitudinal cohort study.
    Ramezankhani A; Azizi F; Hadaegh F
    Cardiovasc Diabetol; 2022 Nov; 21(1):227. PubMed ID: 36324143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.
    Malik S; Wong ND; Franklin SS; Kamath TV; L'Italien GJ; Pio JR; Williams GR
    Circulation; 2004 Sep; 110(10):1245-50. PubMed ID: 15326067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.
    Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
    Eur Heart J; 2007 Apr; 28(7):857-64. PubMed ID: 17303589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trajectory patterns of metabolic syndrome severity score and risk of type 2 diabetes.
    Amouzegar A; Honarvar M; Masoumi S; Khalili D; Azizi F; Mehran L
    J Transl Med; 2023 Oct; 21(1):750. PubMed ID: 37880756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Added value of different metabolic syndrome definitions for predicting cardiovascular disease and mortality events among elderly population: Tehran Lipid and Glucose Study.
    Mozaffary A; Bozorgmanesh M; Sheikholeslami F; Azizi F; Eskandari F; Hadaegh F
    Eur J Clin Nutr; 2014 Jul; 68(7):853-8. PubMed ID: 24865481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The predictive value of metabolic syndrome for cardiovascular and all-cause mortality: Tehran Lipid and Glucose Study.
    Amouzegar A; Mehran L; Hasheminia M; Kheirkhah Rahimabad P; Azizi F
    Diabetes Metab Res Rev; 2017 Jan; 33(1):. PubMed ID: 27155315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome and cardiovascular disease in older people: The cardiovascular health study.
    McNeill AM; Katz R; Girman CJ; Rosamond WD; Wagenknecht LE; Barzilay JI; Tracy RP; Savage PJ; Jackson SA
    J Am Geriatr Soc; 2006 Sep; 54(9):1317-24. PubMed ID: 16970637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical value of metabolic syndrome and its components with respect to sudden cardiac death using different definitions: Two decades of follow-up from the Tehran Lipid and Glucose Study.
    Masrouri S; Moazzeni SS; Cheraghloo N; Azizi F; Hadaegh F
    Cardiovasc Diabetol; 2022 Dec; 21(1):269. PubMed ID: 36463175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort.
    Guembe MJ; Fernandez-Lazaro CI; Sayon-Orea C; Toledo E; Moreno-Iribas C;
    Cardiovasc Diabetol; 2020 Nov; 19(1):195. PubMed ID: 33222691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis.
    Kodama S; Saito K; Tanaka S; Maki M; Yachi Y; Asumi M; Sugawara A; Totsuka K; Shimano H; Ohashi Y; Yamada N; Sone H
    JAMA; 2009 May; 301(19):2024-35. PubMed ID: 19454641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maximal exercise electrocardiographic responses and coronary heart disease mortality among men with metabolic syndrome.
    Lyerly GW; Sui X; Church TS; Lavie CJ; Hand GA; Blair SN
    Mayo Clin Proc; 2010 Mar; 85(3):239-46. PubMed ID: 20160139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous metabolic syndrome severity score and the risk of CVD and all-cause mortality.
    Tang X; Wu M; Wu S; Tian Y
    Eur J Clin Invest; 2022 Sep; 52(9):e13817. PubMed ID: 35598176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of metabolic syndrome, diabetes and prediabetes on cardiovascular events: Tehran lipid and glucose study.
    Hadaegh F; Shafiee G; Ghasemi A; Sarbakhsh P; Azizi F
    Diabetes Res Clin Pract; 2010 Mar; 87(3):342-7. PubMed ID: 20004035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of metabolic syndrome with risk of cardiovascular disease mortality and all-cause mortality among Malaysian adults: a retrospective cohort study.
    Chee Cheong K; Lim KH; Ghazali SM; Teh CH; Cheah YK; Baharudin A; Lim HL; Abdul Hamid AM; Mustapha FI; Omar MA
    BMJ Open; 2021 Aug; 11(8):e047849. PubMed ID: 34408040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different obesity phenotypes, and incident cardiovascular disease and mortality events in elderly Iranians: Tehran lipid and glucose study.
    Mirbolouk M; Asgari S; Sheikholeslami F; Mirbolouk F; Azizi F; Hadaegh F
    Geriatr Gerontol Int; 2015 Apr; 15(4):449-56. PubMed ID: 24750352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of plasma aldosterone with cardiovascular mortality in patients with low estimated GFR: the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study.
    Tomaschitz A; Pilz S; Ritz E; Grammer T; Drechsler C; Boehm BO; März W
    Am J Kidney Dis; 2011 Mar; 57(3):403-14. PubMed ID: 21186074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic Syndrome Components and Long-Term Incidence of Cardiovascular Disease in Eastern Mediterranean Region: A 13-Year Population-Based Cohort Study.
    Mansourian M; Babahajiani M; Jafari-Koshki T; Roohafza H; Sadeghi M; Sarrafzadegan N
    Metab Syndr Relat Disord; 2019 Sep; 17(7):362-366. PubMed ID: 31188051
    [No Abstract]   [Full Text] [Related]  

  • 20. First report on the validity of a continuous Metabolic syndrome score as an indicator for Metabolic syndrome in a national sample of paediatric population - the CASPIAN-III study.
    Shafiee G; Kelishadi R; Heshmat R; Qorbani M; Motlagh ME; Aminaee T; Ardalan G; Taslimi M; Poursafa P; Larijani B
    Endokrynol Pol; 2013; 64(4):278-84. PubMed ID: 24002955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.